The effect of hydroxychloroquine on pregnancy outcomes in patients with unexplained recurrent pregnancy loss: a placebo-controlled study “pilot study”

References

• Ahmadi, M., et al., 2017. Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: non randomized, open-label clinical trial. Immunology Letters, 192, 12–19.
   PubMed Web of Science ®Google Scholar
• Atasever, M., et al., 2016. Diminished ovarian reserve: is it a neglected cause in the assessment of recurrent miscarriage? A cohort study. Fertility and Sterility, 105 (5), 1236–1240.
   PubMed Web of Science ®Google Scholar
• Christiansen, O. B., et al., 2018. ESHRE guideline: recurrent pregnancy loss. Human Reproduction Open, 2018, hoy004-hoy004.
   Google Scholar
• Clowse, M. E., et al., 2006. Hydroxychloroquine in lupus pregnancy. Arthritis and Rheumatism, 54 (11), 3640–3647.
   PubMed Web of Science ®Google Scholar
• Costedoat-Chalumeau, N., et al., 2005. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmunity Reviews, 4 (2), 111–115.
   PubMed Web of Science ®Google Scholar
• DE Moreuil, C., Alavi, Z. and Pasquier, E., 2020. Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage. British Journal of Clinical Pharmacology, 86 (1), 39–49.
   PubMed Web of Science ®Google Scholar
• Discacciati, A., Orsini, N. and Greenland, S., 2015. Approximate Bayesian logistic regression via penalized likelihood by data augmentation. The Stata Journal, 15 (3), 712–736.
   Web of Science ®Google Scholar
• Girardi, G., 2018. Complement activation, a threat to pregnancy. Seminars in Immunopathology, 40 (1), 103–111.
   PubMed Web of Science ®Google Scholar
• Haas, D. M., et al., 2019. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database of Systematic Reviews, 2019, CD003511.
   PubMedGoogle Scholar
• Jeve, Y. B. and Davies, W., 2014. Evidence-based management of recurrent miscarriages. Journal of Human Reproductive Sciences, 7 (3), 159–169.
   PubMedGoogle Scholar
• Kaiser, J. and Branch, D. W., 2016. Recurrent pregnancy loss: generally accepted causes and their management. Clinical Obstetrics and Gynecology, 59 (3), 464–473.
   PubMed Web of Science ®Google Scholar
• Karami, N., et al., 2012. Enhancement of peripheral blood CD56dim cell and NK cell cytotoxicity in women with recurrent spontaneous abortion or in vitro fertilization failure. Journal of Reproductive Immunology, 95 (1–2), 87–92.
   PubMed Web of Science ®Google Scholar
• Kitaya, K., 2011. Prevalence of chronic endometritis in recurrent miscarriages. Fertility and Sterility, 95 (3), 1156–1158.
   PubMed Web of Science ®Google Scholar
• Mcqueen, D. B., et al., 2015. Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss. Fertility and Sterility, 104 (4), 927–931.
   PubMed Web of Science ®Google Scholar
• Medicine, P. C. O. T. A. S. F. R., 2013. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertility and Sterility, 99, 63.
   PubMed Web of Science ®Google Scholar
• Murugappan, G., et al., 2016. Intent to treat analysis of in vitro fertilization and preimplantation genetic screening versus expectant management in patients with recurrent pregnancy loss. Human Reproduction, 31 (8), 1668–1674.
   PubMed Web of Science ®Google Scholar
• Murugappan, G., Ohno, M. S. and Lathi, R. B., 2015. Cost-effectiveness analysis of preimplantation genetic screening and in vitro fertilization versus expectant management in patients with unexplained recurrent pregnancy loss. Fertility and Sterility, 103 (5), 1215–1220.
   PubMed Web of Science ®Google Scholar
• Pasquier, E., et al., 2013. Unexplained pregnancy loss: a marker of basal endothelial dysfunction? Fertility and Sterility, 100 (4), 1013–1017.
   PubMed Web of Science ®Google Scholar
• Pasquier, E., et al., 2019. Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study. BMJ Open, 9 (3), e025649.
   PubMed Web of Science ®Google Scholar
• Pils, S., et al., 2016. Decreased ovarian reserve predicts inexplicability of recurrent miscarriage? A retrospective analysis. PLoS One, 11 (9), e0161606.
   PubMed Web of Science ®Google Scholar
• Qiao, J., 2019. Preconception care of patients with recurrent spontaneous abortion. Reproductive and Developmental Medicine, 3 (2), 63–68.
   Web of Science ®Google Scholar
• Raghupathy, R., et al., 2000. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Human Reproduction, 15 (3), 713–718.
   PubMed Web of Science ®Google Scholar
• Rai, R. and Regan, L., 2006. Recurrent miscarriage. The Lancet, 368 (9535), 601–611.
   PubMed Web of Science ®Google Scholar
• Rey, E., et al., 2003. Thrombophilic disorders and fetal loss: a meta-analysis. The Lancet, 361 (9361), 901–908.
   PubMed Web of Science ®Google Scholar
• Sciascia, S., et al., 2016. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. American journal of obstetrics and gynaecology, 214, 273. e1–273. e8.
   PubMed Web of Science ®Google Scholar
• Tarfaoui, N., et al., 2013. Hydroxychloroquine during pregnancy: a review of retinal toxicity in the newborns. Therapie, 68 (1), 43–47.
   PubMed Web of Science ®Google Scholar
• Vomstein, K., et al., 2021. Immunological risk factors in recurrent pregnancy loss: guidelines versus current state of the art. Journal of Clinical Medicine, 10 (4), 869.
   PubMed Web of Science ®Google Scholar
• Wang, W.-J., et al., 2010. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. Journal of Reproductive Immunology, 84 (2), 164–170.
   PubMed Web of Science ®Google Scholar